Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 1;105(8):1771-1777.
doi: 10.1097/TP.0000000000003427.

Major Thromboembolic Complications in Liver Transplantation: The Role of Rotational Thromboelastometry and Cryoprecipitate Transfusion

Christine Nguyen-Buckley  1 , Wei Gao  2 , Vatche Agopian  3 , Christopher Wray  1 , Randolph H Steadman  1 , Victor W Xia  1
Affiliations
Free article

Major Thromboembolic Complications in Liver Transplantation: The Role of Rotational Thromboelastometry and Cryoprecipitate Transfusion

Christine Nguyen-Buckley et al. Transplantation. .
Free article

Abstract

Background: Although hemorrhage is a major concern during liver transplantation (LT), the risk for thromboembolism is well recognized. Implementation of rotational thromboelastometry (ROTEM) has been associated with the increased use of cryoprecipitate; however, the role of ROTEM-guided transfusion strategy and cryoprecipitate administration in the development of major thromboembolic complications (MTCs) has never been documented.

Methods: We conducted a study on patients undergoing LT before and after the implementation of ROTEM. We defined MTC as intracardiac thrombus, pulmonary embolism, hepatic artery thrombosis, and ischemic stroke in 30 d after LT. We used a propensity score to match patients during the 2 study periods.

Results: Among 2330 patients, 119 (4.9%) developed MTC. The implementation of ROTEM was significantly associated with an increase in cryoprecipitate use (1.1 ± 1.1 versus 2.9 ± 2.3 units, P < 0.001) and MTC (4.2% versus 9.5%, P < 0.001). Further analysis demonstrated that the use of cryoprecipitate was an independent risk factor for MTC (odds ratio 1.1, 95% confidence interval 1.04-1.24, P = 0.003). Patients with MTC had significantly lower 1-y survival.

Conclusions: Our study suggests that the implementation of ROTEM and the use of cryoprecipitate play significant roles in the development of MTC in LT. The benefits and risks of cryoprecipitate transfusion should be carefully evaluated before administration.

PubMed Disclaimer

Comment in

References

    1. Warnaar N, Lisman T, Porte RJ. The two tales of coagulation in liver transplantation. Curr Opin Organ Transplant. 2008;13:298–303.
    1. Feltracco P, Barbieri S, Cillo U, et al. Perioperative thrombotic complications in liver transplantation. World J Gastroenterol. 2015;21:8004–8013.
    1. Groose MK, Aldred BN, Mezrich JD, et al. Risk factors for intracardiac thrombus during liver transplantation. Liver Transpl. 2019;25:1682–1689.
    1. Xia VW, Ho JK, Nourmand H, et al. Incidental intracardiac thromboemboli during liver transplantation: incidence, risk factors, and management. Liver Transpl. 2010;16:1421–1427.
    1. Fukazawa K, Pretto EA Jr, Nishida S, et al. Factors associated with mortality within 24h of liver transplantation: an updated analysis of 65,308 adult liver transplant recipients between 2002 and 2013. J Clin Anesth. 2018;44:5–40.